Immunovant, Inc. (IMVT) Competitors & Peers
The 5 largest companies in the same industry as Immunovant, Inc., by market value — each comparable links to its own dossier. Numbers are code-computed, never estimated.
| Ticker | Relationship | Price | Comparables |
|---|---|---|---|
| VRTX | Peer | $526.19 | P/E 30.2RSI 51Cap 133.4 B |
| REGN | Peer | $788.04 | P/E 19.9RSI 54Cap 82.8 B |
| ARGX | Peer | $959.49 | P/E 36.2RSI 42Cap 59.4 B |
| RVMD | Peer | $204.97 | RSI 41Cap 41.4 B |
| ALNY | Peer | $255.96 | P/E 43.3RSI 51Cap 33.2 B |
How these relationships were derived
Every relationship below carries its provenance. A confirmed edge is sourced from a public filing or disclosure and links to it; an AI-inferred edge is surfaced by the relationship model and is unverified — shown for color, not as evidence.
Model-inferred relationships (unverified)
Suggested by the relationship model, with no public source on file. Treat each as a lead worth checking, not as evidence.
- IQVPartner
IQVIA provides clinical trial management and contract research services (CRO) to support drug development.
Model-inferred, unverified — treat as a lead, not evidence - AMZNSupplier
Utilizes AWS cloud infrastructure to host genomic sequencing data and clinical trial databases.
Model-inferred, unverified — treat as a lead, not evidence - PFECompetitor
Competes in licensing and commercializing drug therapies targeting similar clinical indications.
Model-inferred, unverified — treat as a lead, not evidence